메뉴 건너뛰기




Volumn 22, Issue 6, 1999, Pages 1001-1002

Implanted insulin pump may represent a chance for young women with unstable type 1. Diabetes to give birth [5]

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; DIHYDRALAZINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN A1C; INSULIN; POLOXAMER;

EID: 0033012389     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.22.6.1001     Document Type: Letter
Times cited : (2)

References (7)
  • 2
    • 0031710017 scopus 로고    scopus 로고
    • Long-term safety and efficacy of intraperitoneal insulin infusion by means of implantable pumps
    • Pinget M, Jeandidier N: Long-term safety and efficacy of intraperitoneal insulin infusion by means of implantable pumps. Horm Metab Res 30:475-486, 1998
    • (1998) Horm Metab Res , vol.30 , pp. 475-486
    • Pinget, M.1    Jeandidier, N.2
  • 6
    • 0028043518 scopus 로고
    • Management through pregnancy of a patient with an implantable programmable insulin infusion pump
    • Gallacher SJ, Mac Cuish AC, Lunan CB, Paterson KR: Management through pregnancy of a patient with an implantable programmable insulin infusion pump. Practical Diabetes 11:92-194, 1994
    • (1994) Practical Diabetes , vol.11 , pp. 92-194
    • Gallacher, S.J.1    Mac Cuish, A.C.2    Lunan, C.B.3    Paterson, K.R.4
  • 7
    • 0031937357 scopus 로고    scopus 로고
    • Local adverse events associated with long-term treatment by implantable insulin pumps
    • Belicar P, Lassmann-Vague V, the EVADIAC study group: Local adverse events associated with long-term treatment by implantable insulin pumps. Diabetes Care 21:325-326, 1998
    • (1998) Diabetes Care , vol.21 , pp. 325-326
    • Belicar, P.1    Lassmann-Vague, V.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.